Abstract:Metformin, a widely used antidiabetic drug, possesses other beneficial activities, including cardiovascular protection, anti-tumorigenesis, antiaging, and weight control. This Cutting-Edge Research Highlights outlines some latest basic research discoveries on metformin’s suppression of mitochondrial electron transport chain (METC) in the intervention of pulmonary inflammatory disorders, including tuberculosis and acute respiratory distress syndrome in animal models. These novel discoveries further support metformin as a pleiotropic drug for treating diverse diseases. (First online: February 19, 2023) REFERENCES Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab 2014; 20(6):953–66. doi: https://dx.doi.org/10.1016/j.cmet.2014.09.018 Vasan K, Werner M, Chandel NS. Mitochondrial metabolism as a target for cancer therapy. Cell Metab 2020; 32(3):341–52. doi: https://dx.doi.org/10.1016/j.cmet.2020.06.019 Kulkarni AS, Gubbi S, Barzilai N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab 2020; 32(1):15–30. doi: https://dx.doi.org/10.1016/j.cmet.2020.04.001 Day EA, Ford RJ, Smith BK, Mohammadi-Shemirani P, Morrow MR, Gutgesell RM, et al. Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat Metab 2019; 1(12):1202–8. doi: https://dx.doi.org/10.1038/s42255-019-0146-4 Coll AP, Chen M, Taskar P, Rimmington D, Patel S, Tadross JA, et al. GDF15 mediates the effects of metformin on body weight and energy balance. Nature 2020; 578(7795):444–8. doi: https://dx.doi.org/10.1038/s41586-019-1911-y Roca FJ, Whitworth LJ, Prag HA, Murphy MP, Ramakrishnan L. Tumor necrosis factor induces pathogenic mitochondrial ROS in tuberculosis through reverse electron transport. Science 2022; 376(6600):eabh2841. doi: https://dx.doi.org/10.1126/science.abh2841 Xian H, Liu Y, Rundberg Nilsson A, Gatchalian R, Crother TR, Tourtellotte WG, et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 2021; 54(7):1463–77 e11. doi: https://dx.doi.org/10.1016/j.immuni.2021.05.004 Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature 2018; 560(7717):198–203. doi: https://dx.doi.org/10.1038/s41586-018-0372-z Billingham LK, Stoolman JS, Vasan K, Rodriguez AE, Poor TA, Szibor M, et al. Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation. Nat Immunol 2022; 23(5):692–704. doi: https://dx.doi.org/10.1038/s41590-022-01185-3 Guo H, Wang Q, Ghneim K, Wang L, Rampanelli E, Holley-Guthrie E, et al. Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication. Nat Immunol 2021; 22(4):423–33. doi: https://dx.doi.org/10.1038/s41590-021-00898-1

Metformin Inhibits Mitochondrial Complex I To Promote Health

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis

Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, "futile" fatty acid cycling, and FADH2 oxidation

Role of Mitochondria in the Mechanism(s) of Action of Metformin

Metformin Induces Mitochondrial Fission and Reduces Energy Metabolism by Targeting Respiratory Chain Complex I in Hepatic Stellate Cells to Reverse Liver Fibrosis.

Metformin, a “Wonder Drug”, Targets METC for Pulmonary Protection

The Therapeutic Activities of Metformin: Focus on the Nrf2 Signaling Pathway and Oxidative Stress Amelioration

Metformin is a Novel Suppressor for Transforming Growth Factor (Tgf)-Β1.

Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism

Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759

Metformin inhibits mitochondrial dysfunction and apoptosis in cardiomyocytes induced by high glucose via upregulating AMPK activity

Systematic Investigation of Dose-Dependent Protein Thermal Stability Changes to Uncover the Mechanisms of the Pleiotropic Effects of Metformin

Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria

295-LB: Metformin Biphasic Effect on Human Cardiac Mitochondria

Mitophagy as a potential mediator for the anti‐inflammatory effects of metformin in human retinal pigment epithelium cells

Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPKα

The acute removal of metformin induces mitochondrial remodeling and increases mitochondrial respiration

Biphasic Effect of Metformin on Human Cardiac Energetics

Metformin Inhibits ROS Production by Human M2 Macrophages via the Activation of AMPK

Metformin: a metabolic modulator

Metformin leads to accumulation of reactive oxygen species by inhibiting the NFE2L1 expression in human hepatocellular carcinoma cells